Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Obstet Gynaecol Res ; 38(5): 810-6, 2012 May.
Article in English | MEDLINE | ID: mdl-22435532

ABSTRACT

AIM: Inflammation is as an important factor in ovulation with the active participation of leucocytes and their inflammatory mediators. The present study was performed to compare the activity of the inflammatory enzymes myeloperoxidase (MPO) and N-acetylglucosaminidase (NAG) in patients with endometriosis-related infertility and in normally ovulating women undergoing intracytoplasmic sperm injection (ICSI). MATERIAL AND METHODS: This prospective study included infertile women undergoing ICSI treatment. These women were divided into two groups: endometriosis anovulation (n = 18) and normally ovulating (n = 20). NAG and MPO activity was evaluated colorimetrically in serum and in follicular fluids obtained at the time of oocyte retrieval. RESULTS: There was a significant correlation between the serum and follicular fluid activities of NAG and MPO (τ = 0.256, P = 0.025; and τ = -0.234, P = 0.041; respectively). Both serum and follicular fluid NAG activities were higher in patients with endometriosis compared to the control group (P < 0.001). MPO follicular fluid activity was lower in patients with endometriosis compared to normally ovulating women (P = 0.016). CONCLUSION: Infertile patients with endometriosis show a distinct pattern of serum and follicular fluid macrophage/neutrophil activation compared to normally ovulating women undergoing ICSI, which may reflect the role of immune and inflammatory alterations in endometriosis-related infertility.


Subject(s)
Acetylglucosaminidase/metabolism , Endometriosis/enzymology , Infertility, Female/enzymology , Peroxidase/metabolism , Sperm Injections, Intracytoplasmic , Adult , Endometriosis/complications , Female , Follicular Fluid/enzymology , Humans , Infertility, Female/etiology , Infertility, Female/therapy , Inflammation/enzymology , Prospective Studies
2.
Reprod Sci ; 19(7): 704-11, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22344731

ABSTRACT

The aim of this study was to evaluate inflammatory response in chronic anovulating infertility women undergoing intracytoplasmic sperm injection. Thirteen infertile women with chronic anovulation and 23 normally ovulating women were prospectively evaluated. N-acetylglucosaminidase (NAG), myeloperoxidase (MPO), monocyte chemoattractant protein 1 (MCP-1), and C-reactive protein (CRP) concentrations were evaluated in serum and follicular fluid. Women with chronic anovulation presented higher NAG and MPO activity in follicular fluid when compared with normally ovulating women. Serum MPO activity was higher in the control group compared to the chronic anovulation group. Both serum and follicular fluid CRP concentrations were higher in women with chronic anovulation in comparison with the control group. Higher MCP-1 follicular fluid concentrations and serum levels of CRP were associated with the occurrence of ovarian hyperstimulation syndrome. Patients with chronic anovulation exhibited significantly higher follicle macrophage/neutrophil activation as well as unspecific inflammatory response by comparison with normally ovulating women.


Subject(s)
Anovulation/immunology , Infertility, Female/therapy , Macrophage Activation , Neutrophil Activation , Sperm Injections, Intracytoplasmic , Adult , Anovulation/blood , Anovulation/metabolism , Anovulation/physiopathology , Biomarkers/blood , Biomarkers/metabolism , Case-Control Studies , Female , Follicular Fluid/immunology , Follicular Fluid/metabolism , Humans , Infertility, Female/etiology , Prospective Studies , Young Adult
3.
Arch Gynecol Obstet ; 274(1): 21-4, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16408185

ABSTRACT

OBJECTIVE: To compare the short-term results of the quality of life and satisfaction of patients submitted to total abdominal hysterectomy (TAH) and vaginal hysterectomy (VH) for benign uterine disease. METHODS: Women referred for hysterectomy for uterine myoma were randomized to TAH (n=30) or VH (n=30). The exclusion criteria were uterine prolapse, indication associated surgical procedures and uterine size > or =300 cm3. After a month, follow-up questionnaires had a response rate of 100%, and consisted of an interview with application of SF-36 questionnaire (functional capacity, physical aspect and pain) and evaluation of satisfaction rate. RESULTS: There were no differences in the patients' mean age, parity, body mass index, preoperative hemoglobin levels and uterine size between groups. Lower postoperative quality-of-life scores were found in the TAH group when compared to the VH group in functional capacity (P=0.002), physical aspect (P=0.008) and pain (P=0.002). The general satisfaction rate with the surgery was similar in the two groups of patients (P=0.147). However, a higher rate of patients submitted to VH would choose the same therapeutic modality (65.5 vs 90%; P=0.021). CONCLUSIONS: A better postoperative quality of life (functional capacity, physical aspect and pain) and higher satisfaction rate was found in the VH when compared to TAH.


Subject(s)
Hysterectomy, Vaginal , Leiomyomatosis/surgery , Patient Satisfaction , Quality of Life/legislation & jurisprudence , Uterine Neoplasms/surgery , Adult , Female , Follow-Up Studies , Health Surveys , Humans , Interviews as Topic , Laparotomy , Middle Aged
4.
Cancer Invest ; 22(5): 723-9, 2004.
Article in English | MEDLINE | ID: mdl-15581054

ABSTRACT

Angiogenesis and inflammation play critical roles in tumor growth. Using an in vivo tumor model, we report that thalidomide (100 mg kg(-1)day(-1)) or clotrimazole (120 mg kg(-1) day(-1)), inhibit blood vessel formation (determined by hemoglobin content), leukocyte recruitment [myeloperoxidase (MPO) activity; N-acetylglucosa-minidase (NAG) activity], and vascular endothelial growth factor production. Inhibition of angiogenesis ranged from 35% to 65%. Clotrimazole was the most potent antiangiogenic compound and the agent capable of inhibiting tumor growth. Thalidomide was able to reduce the inflammatory reaction (MPO and NAG activities) by 50% to 70%, but was unable to delay tumor development. These results suggest that for this type of solid tumor the degree of neovascularization, rather than inhibition of inflammatory cell recruitment, is a determinant factor in tumor development. As the contribution of angiogenesis and inflammation to cancer progression vary markedly among different tumor types, it may be relevant to consider these factors in cancer therapy using antiangiogenesis/antiinflammatory approaches.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Carcinoma, Ehrlich Tumor/drug therapy , Chemotaxis, Leukocyte/drug effects , Neovascularization, Pathologic , Vascular Endothelial Growth Factor A/drug effects , Acetylglucosaminidase/drug effects , Animals , Anti-Inflammatory Agents/pharmacology , Carcinoma, Ehrlich Tumor/blood supply , Clotrimazole/pharmacology , Male , Mice , Peroxidase/drug effects , Thalidomide/pharmacology , Vascular Endothelial Growth Factor A/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...